Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice

A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care

(2014) M. Trento et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Antidepressant-like effect of pioglitazone in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway

(2011) Mohammad Salehi Sadaghiani et al.   BEHAVIOURAL BRAIN RESEARCH

Associations between posttraumatic stress disorder and hemoglobin A1C in low-income minority patients with diabetes

(2011) Samantha A. Miller et al.   GENERAL HOSPITAL PSYCHIATRY

Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population

(2011) Tamara Weiss et al.   GENERAL HOSPITAL PSYCHIATRY

Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms

(2011) Serge C. Thal et al.   JOURNAL OF NEUROTRAUMA

Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones

(2011) Min Lu et al.   NATURE MEDICINE

Leptin as a Neuroactive Agent

(2011) Melanie L. Zupancic et al.   PSYCHOSOMATIC MEDICINE

Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study

(2011) Natalie L. Rasgon et al.   TheScientificWorldJOURNAL

Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder

(2010) T. R. Castañeda et al.   DIABETOLOGIA

Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance

(2010) Isabel García-Tornadú et al.   ENDOCRINOLOGY

Neurobehavioral deficits in db/db diabetic mice

(2010) Ajaykumar N. Sharma et al.   PHYSIOLOGY & BEHAVIOR

Effect of Drugs Interacting With the Dopaminergic Receptors on Glucose Levels and Insulin Release in Healthy and Type 2 Diabetic Subjects

(2009) Freddy Contreras et al.   AMERICAN JOURNAL OF THERAPEUTICS

Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests

(2009) Amany Ali Eissa Ahmed et al.   BEHAVIOURAL PHARMACOLOGY

Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats

(2009) Ryosuke Tsuruta et al.   BRAIN RESEARCH

Cardiovascular and autonomic phenotype ofdb/dbdiabetic mice

(2009) Danielle Senador et al.   EXPERIMENTAL PHYSIOLOGY

Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study

(2009) B. Koopmans et al.   FAMILY PRACTICE

The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus

(2009) Peter A. Hall et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Should we screen for emotional distress in type 2 diabetes mellitus?

(2009) François Pouwer   Nature Reviews Endocrinology

Recent Developments in the Design of Anti-Depressive Therapies: Targeting the Serotonin Transporter

(2008) S. Butler et al.   CURRENT MEDICINAL CHEMISTRY

Anxiety and depression symptoms in patients with diabetes

(2008) M. M. Collins et al.   DIABETIC MEDICINE

Cerebrospinal fluid: identification of diagnostic markers for schizophrenia

(2008) Emanuel Schwarz et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory

(2008) John I Malone et al.   PEDIATRIC DIABETES

Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review

(2007) O. Sentissi et al.   SCHIZOPHRENIA BULLETIN